Reporting to the Medical Lead, this role will contribute to the development and execution of the clinical strategy and plans for Idera’s Oncology programs with the Company’s primary clinical asset, IMO-2125. This role provides medical and scientific knowledge to guide and support the strategy and execution of Idera’s clinical development plan. This role works collaboratively with multi-disciplinary teams responsible for the design, implementation, monitoring, analysis, and reporting of studies conducted within Idera’s immuno-oncology portfolio to ensure the program meets the needs of patients and Idera’s business. This role will influence both internal and external audiences in a high impact, highly visible role as it actively contributes to the dynamic and innovative culture within Idera. More specifically, this role collaborates with the team to design, plan, and implement the overall direction of clinical research projects including development of study specific documents such as protocols and informed consents, regulatory documents as well as performing data review and analyzes and assisting with site visits and training activities.